| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1373415 | Bioorganic & Medicinal Chemistry Letters | 2010 | 6 Pages |
Abstract
Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease is described. The identified inhibitors bearing an amino nitrile warhead in P1 exhibit low nanomolar in vitro potency against cruzipain. Further SAR in P2 portion led to the identification of compounds, such as 26, that have a unique selectivity profile against other cysteine proteases and offering new opportunities for safer treatment of Chagas disease.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Christian Beaulieu, Elise Isabel, Angélique Fortier, Frédéric Massé, Christophe Mellon, Nathalie Méthot, Momar Ndao, Deborah Nicoll-Griffith, Doris Lee, Hyeram Park, W. Cameron Black,